The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrafalgar Prop Regulatory News (TRAF)

Share Price Information for Trafalgar Prop (TRAF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0425
Bid: 0.04
Ask: 0.045
Change: 0.00 (0.00%)
Spread: 0.005 (12.50%)
Open: 0.0425
High: 0.0425
Low: 0.0425
Prev. Close: 0.0425
TRAF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director loans

6 Sep 2017 11:57

RNS Number : 9846P
Trafalgar New Homes PLC
06 September 2017
 

 

6 September 2017

Trafalgar New Homes plc

(the "Company")

 

Director loans

 

Speldhurst loans

 

Trafalgar New Homes plc (AIM: TRAF), the residential property developer operating in southeast England, provides further details on its site in Speldhurst, Tunbridge Wells, Kent (the "Speldhurst Site"). The Speldhurst Site was acquired with the benefit of planning permission for the demolition of the existing property and the erection of a substantial new build detached house on the site, the building of which is progressing and scheduled for completion in October 2017. 

 

The Speldhurst Site is held on trust for the benefit of Combe Bank Homes Limited ("CBH"), a subsidiary of the Company, by Alex Johnson, a director of the Company. The Speldhurst Site was acquired by Mr Johnson on 17 June 2016 and a declaration of trust was entered into on the same date for CBH to be the beneficial owner of the Speldhurst Site (the "Declaration of Trust"). The Speldhurst Site was acquired for £670,000, plus costs of purchase, which was funded by a loan of £221,000 from Lloyds Bank in the name of Mr Johnson and the balance was paid by CBH in cash.

 

In addition, Lloyds Bank has provided a loan facility of up to a further £614,000 to Mr Johnson for development of the Speldhurst Site (the "Facility"), of which £300,455 has been drawn to date and made available to CBH by Mr Johnson. The Facility can only be drawn against quantity surveyor certificates of work carried out on the site and further drawings under the Facility are expected to be made in future for the benefit of CBH (up to the available balance of £313,545).

 

The Lloyds Bank loans are repayable on 31 January 2018 and attract interest at an annual rate of 5.2% over the official bank rate of The Bank of England from time to time, which is paid monthly by CBH. Chris Johnson, the father of Alex Johnson and Chief Executive of the Company, has provided a personal guarantee to Lloyds Bank in respect of its loan to Alex Johnson.

 

As a result of the Declaration of Trust, Mr Johnson has not and will not receive any benefit or gain from the Speldhurst Site nor from the Lloyds Bank loan. CBH has accepted responsibility for the repayment of the loan and interest payments on it on the same terms as Mr Johnson has with Lloyds Bank. However, the effect of the arrangement is that Mr Johnson has loaned to CBH £551,455 to date and expects to loan to CBH up to a further £283,545 (in line with the remaining availability under his Lloyds Bank facilities).

 

The trust and loan arrangements between CBH and Alex Johnson in respect of the Speldhurst Site are related party transactions under the AIM Rules for Companies. Accordingly, the directors independent of the transactions consider, having consulted with Allenby Capital Limited, the Company's Nominated Adviser, that these arrangements are fair and reasonable insofar as the Company's shareholders are concerned. 

 

Working capital loan

 

On 27 June 2013, CBH entered into a loan agreement with Chris Johnson, Chief Executive of the Company, for working capital purposes ("CBH Loan"). Under the terms of the CBH Loan, Mr Johnson is entitled to receive interest of 5% per annum, payable annually in arrears. On 6 September 2017, Mr Johnson agreed to waive interest due on the CBH Loan for the year ended 31 March 2017, which would have totalled £106,096. The CBH Loan will continue to accrue interest for the year ending 31 March 2018. The outstanding balance on the CBH Loan, which currently stands at £2,188,802, was repayable by 31 March 2017, but Mr Johnson has today agreed to extend the repayment date of the CBH Loan until 31 August 2018. CBH will make repayments on the CBH Loan periodically, depending on its working capital requirements, and Mr Johnson has confirmed he will continue to support the Company's working capital requirements as needed.

 

The extension of the repayment date and waiver of interest payments on the CBH Loan is a related party transaction under the AIM Rules for Companies. Accordingly, the directors independent of the transaction consider, having consulted with Allenby Capital Limited, the Company's Nominated Adviser, that the amendments to the CBH Loan are fair and reasonable insofar as the Company's shareholders are concerned. 

 

Enquiries:

 

Trafalgar New Homes plc

Christopher Johnson

 

+44 (0)1732 700 000

Allenby Capital Ltd - Nominated Adviser and Broker

Jeremy Porter/James Reeve

 

+44 (0)20 3328 5656

Yellow Jersey PR Limited

Felicity Winkles/Henry Wilkinson

+44 (0)7748 843 871

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSSIFSMFWSEIU
Date   Source Headline
23rd Apr 20244:41 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSDebt Conversion and Convertible Loan Note Issuance
10th Jan 202411:59 amRNSResult of AGM
18th Dec 20237:30 amRNSRestoration - Trafalgar Property Group PLC
15th Dec 20234:49 pmRNSHalf-year Report
15th Dec 20234:48 pmRNSFinal Results
2nd Oct 20237:30 amRNSSuspension - Trafalgar Property Group plc
26th Sep 20232:00 pmRNSDelay to Publication of Annual Report and Accounts
25th Sep 20234:50 pmRNSTR-1: notification of major holdings
18th Sep 20233:32 pmRNSTR-1: Notification of major holdings
18th Sep 20233:27 pmRNSTR-1: Notification of major holdings
18th Aug 20237:00 amRNSPlacing and Total Voting Rights
15th Aug 20233:17 pmRNSTR-1: Notification of major holdings
26th Jul 20231:54 pmRNSTrading Update
30th Jun 20232:36 pmRNSDirector Disclosure
24th Mar 202312:50 pmRNSDirectorate Change
13th Jan 202312:53 pmRNSTR-1: Notification of major holdings
13th Jan 202312:52 pmRNSTR-1: Notification of major holdings
13th Jan 202312:52 pmRNSTR-1: Notification of major holdings
28th Dec 20227:00 amRNSHalf-year Report
12th Dec 20227:00 amRNSTR-1: notification of major holdings
8th Dec 202212:10 pmRNSResult of General Meeting
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20227:00 amRNSProposed Acquisition of Hydroponics R&D Facility
21st Oct 202211:45 amRNSResult of AGM
29th Sep 20229:00 amRNSFinal Results
11th Jul 20227:00 amRNSDebt Consolidation
22nd Jun 20227:00 amRNSTrading update on Property Interests
16th Jun 202210:32 amRNSTR-1: Notification of major holdings
15th Jun 202211:06 amRNSTR-1: Notification of major holdings
15th Jun 202211:06 amRNSTR-1: Notification of major holdings
15th Jun 202211:05 amRNSTR-1: Notification of major holdings
1st Jun 20223:07 pmRNSPlacing and Total Voting Rights
12th May 202211:05 amRNSSecond Price Monitoring Extn
12th May 202211:00 amRNSPrice Monitoring Extension
12th May 20229:05 amRNSSecond Price Monitoring Extn
12th May 20229:00 amRNSPrice Monitoring Extension
11th May 202210:54 amRNSResponse to Share Price Movement
11th May 20227:00 amRNSBoard Appointment
24th Dec 20217:00 amRNSHalf-year Report
22nd Dec 20215:23 pmRNSTR-1: Notification of major holdings
22nd Nov 202110:29 amRNSWorking Capital CLN
30th Sep 202111:51 amRNSResult of AGM
7th Sep 20217:00 amRNSFinal Results
19th Feb 20214:41 pmRNSSecond Price Monitoring Extn
19th Feb 20214:36 pmRNSPrice Monitoring Extension
19th Feb 202111:05 amRNSSecond Price Monitoring Extn
19th Feb 202111:00 amRNSPrice Monitoring Extension
19th Feb 20219:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.